Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/17/24 17:31 | 1/16/24 | ADAP | Health | BioPrd | Biological Products, (No Diag | Rawcliffe Adrian | X0 | DO | CEO | 5 | S.m | -75 | 0.8999 | 0 | -83 | 45 | D | |||||||||||||||
1/17/24 17:31 | 1/16/24 | ADAP | Health | BioPrd | Biological Products, (No Diag | Norry Elliot | X0 | O | Chief Me | 3 | S.m | -28 | 0.8147 | 0 | -35 | 19 | D | |||||||||||||||
1/17/24 17:30 | 1/16/24 | ADAP | Health | BioPrd | Biological Products, (No Diag | Lunger John | X0 | O | Chief Pa | 4 | S.m | -35 | 0.8786 | 0 | -40 | 19 | D | |||||||||||||||
1/17/24 17:30 | 1/16/24 | ADAP | Health | BioPrd | Biological Products, (No Diag | Bertrand William C Jr | X0 | O | COO | 3 | S.m | -32 | 0.8719 | 0 | -37 | 20 | D | |||||||||||||||
7/10/23 17:01 | 7/10/23 | ADAP | Health | BioPrd | Biological Products, (No Diag | Menzel Garry E | X0 | D | 1 | S | -43 | 0.9108 | 0 | -48 | 75 | D | ||||||||||||||||
1/31/23 21:02 | 1/31/23 | ADAP | Health | BioPrd | Biological Products, (No Diag | Piccina Cintia | X0 | O | Chief Co | 1 | S | -22 | 1.87 | 0 | -12 | 20 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |